Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development

Journal of Medical Virology

Volumn 81, Issue 4, 2009, Pages 713-721

  Winer, Rachel L ^a   Harris, Tiffany G ^a,d   Xi, Long Fu ^a   Jansen, Kathrin U ^b,e   Hughes, James P ^a   Feng, Qinghua ^a   Welebob, Carolee ^b   Ho, Jesse ^a   Lee, Shu Kuang ^a   Carter, Joseph J ^c   Galloway, Denise A ^a,c   Kiviat, Nancy B ^a   Koutsky, Laura A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^e PFIZER INC   (United States)

Author keywords

Cervical pre Cancer; HPV; MRNA; Viral load

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INCIDENCE; MAJOR CLINICAL STUDY; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA IN SITU; VERRUCA VULGARIS; VIRUS DETECTION; ADOLESCENT; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PRECANCER; RISK FACTOR; UTERINE CERVIX; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION; VIRUS LOAD;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16;

MESSENGER RNA; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; VIRUS DNA;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; RISK FACTORS; RNA, MESSENGER; VAGINAL SMEARS; VIRAL LOAD; YOUNG ADULT;

EID: 62849101633     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21450     Document Type: Article

References (60)

1. Badaracco G, Venuti A, Sedati A, Marcante ML. 2002. HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness. J Med Virol 67: 574-582.
2. Baer A, Saroiu S, Koutsky LA. 2002. Obtaining sensitive data through the Web: An example of design and methods. Epidemiology 13:640-645.
3. Bleeker MC, Hogewoning CJ, Berkhof J, Voorhorst FJ, Hesselink AT, van Diemen PM, van den Brule AJ, Snijders PJ, Meijer CJ. 2005. Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis 41:612-620.
4. Carcopino X, Henry M, Benmoura D, Fallabregues AS, Richet H, Boubli L, Tamalet C. 2006. Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy. J Med Virol 78:1131-1140.
5. Castle PE, Wacholder S, Sherman ME, Lorincz AT, Glass AG, Scott DR, Rush BB, Demuth F, Schiffman M. 2002. Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women. Cancer 95:2145- 2151.
6. Cricca M, Morselli-Labate AM, Venturoli S, Ambretti S, Gentilomi GA, Gallinella G, Costa S, Musiani M, Zerbini M. 2007. Viral DNAload, physicalstatus andE2/E6ratioas markers togradeHPV16positive women for high-grade cervical lesions. Gynecol Oncol 106:549-557.
7. Cubie HA, Seagar AL, McGoogan E, Whitehead J, Brass A, Arends MJ, Whitley MW. 2001. Rapid real time PCR to distinguish between high risk human papillomavirus types 16 and 18. Mol Pathol 54:24-29.
8. Dalstein V, Riethmuller D, Pretet J-L, Carval KLB, Sautiere J-L, Carbillet J-P, Kantelip B, Schaal J-P, Mougin C. 2003. Persistence and load of high-risk HPV are predictors for development of high- grade cervical lesions: A longitudinal French cohort study. Int J Cancer 106:396-403.
9. Dillner J, Lehtinen M, Bjorge T, Luostarinen T, Youngman L, Jellum E, Koskela P, Gislefoss RE, Hallmans G, Paavonen J, Sapp M, Schiller JT, Hakulinen T, Thoresen S, Hakama M. 1997. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst 89:1293-1299.
10. Fiander AN, Hart KW, Hibbitts SJ, Rieck GC, Tristram AJ, Beukenholdt RW, Powell NG. 2007. Variation in human papillo- mavirus type-16 viral load within different histological grades of cervical neoplasia. JMed Virol 79:1366-1369.
11. Flores R, Papenfuss M, Klimecki WT, Giuliano AR. 2006. Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia. Int J Cancer 118:1187-1193.
12. Forslund O, Lindqvist P, Haadem K, Czegledy J, Hansson BG. 1997. HPV 16 DNA and mRNA in cervical brush samples quantified by PCR and microwell hybridization. J Virol Methods 69:209-222.
13. Gravitt PE, Burk RD, Lorincz A, Herrero R, Hildesheim A, Sherman ME, Bratti MC, Rodriguez AC, Helzlsouer KJ, SchiffmanM. 2003. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol Biomarkers Prev 12:477-484.
14. Gravitt PE, KovacicMB, Herrero R, Schiffman M, Bratti C, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Rodriguez AC, Burk RD. 2007. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer 121:2787-2793.
15. Healey SM, Aronson KJ, Mao Y, Schlecht NF, Mery LS, Ferenczy A, Franco EL. 2001. Oncogenic human papillomavirus infection and cervical lesions in aboriginal women of Nunavut, Canada. Sex Transm Dis 28:694-700.
16. Hernandez-Hernandez DM, Ornelas-Bernal L, Guido- Jimenez M, Apresa-Garcia T, Alvarado- Cabrero I, Salcedo- Vargas M, Mohar- Betancourt A, Garcia-Carranca A. 2003. Association between high- risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women. Gynecol Oncol 90:310-317.
17. Hesselink AT, van den Brule AJ, Brink AA, Berkhof J, van Kemenade FJ, Verheijen RH, Snijders PJ. 2004. Comparison ofhybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples. Cancer 102:11-18.
18. Ho L, Terry G, Mansell B, Butler B, Singer A. 1994. Detection of DNA and E7 transcripts of human papillomavirus types. 16, 31 and 33, TGF beta and GM-CS: Transcripts in cervical cancers and precancers. Arch Virol 139:79-85.
19. Ho GY, Palan PR, Basu J, Romney SL, Kadish AS, Mikhail M, Wassertheil-Smoller S, Runowicz C, Burk RD. 1998a. Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int J Cancer 78:594-599.
20. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. 1998b. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338:423-428.
21. Ho CM, Chien TY, Huang SH, Lee BH, Chang SF. 2006. Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer. Gynecol Oncol 102:54-60.
22. Huang Y, Huang MN, Li N, Li XG, Li N, Wu LY. 2007. Association between human papillomavirus DNA load and development of cervical intraepithelial neoplasia and cervical cancer. Int J Gynecol Cancer 18:755-760.
23. Ikenberg H, Goppinger A, Bauer H, Schmitt B. 1997. Semiquantitative analysis of human papillomavirus DNA in cervical intraepithelial neoplasia by a differential polymerase chain reaction. J Obstet Gynaecol 17:176-179.
24. Josefsson AM, Magnusson PK, Ylitalo N, Sorensen P, Qwarforth- Tubbin P, Andersen PK, Melbye M, Adami HO, Gyllensten UB. 2000. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: A nested case-control study. Lancet 355:2189-2193.
25. Koutsky LA, Kiviat NB, Koutsky LA, Kiviat NB. 1999. Human papillomavirus infections. In: Holmes KK, Sparling PF, Mardh P-A, Lemon SM, Stamm WE, Piot P, editors. Sexually transmitted diseases. 3rd edition. New York: McGraw-Hill. pp. 347-360. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. 1994. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA 271:1866-1869.
26. Lai HC, Peng MY, Nieh S, Yu CP, Chang CC, Lin YW, Sun CA, Chu TY. 2006. Differential viral loads of human papillomavirus 16 and 58 infections in the spectrum of cervical carcinogenesis. Int J Gynecol Cancer 16:730-735.
27. Lamarcq L, Deeds J, Ginzinger D, Perry J, Padmanabha S, Smith- McCune K. 2002. Measurements of human papillomavirus transcripts by real time quantitative reverse transcription-polymerase chain reaction in samples collected for cervical cancer screening. J Mol Diagn4:97-102.
28. Lillo FB, Lodini S, Ferrari D, Stayton C, Taccagni G, Galli L, Lazzarin A, Uberti-Foppa C. 2005. Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection. Clin Infect Dis 40:451 -457.
29. Lo KW, Yeung SW, Cheung TH, Siu NS, Kahn T, Wong YF. 2005. Quantitative analysis of human papillomavirus type 16 in cervical neoplasm: A study in Chinese population. J Clin Virol 34:76-80. Lowy DR, Schiller JT. 1998. Papillomaviruses and cervical cancer: Pathogenesis and vaccine development. J Natl Cancer Inst Monogr 23:27-30.
30. Mao C, Hughes JP, Kiviat N, Kuypers J, Lee SK, Adam DE, Koutsky LA. 2003. Clinical findings among young women with genital human papillomavirus infection. Am J Obstet Gynecol 188:677-683.
31. Moberg M, Gustavsson I, Gyllensten U. 2004. Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. Int J Cancer 112:854-859.
32. Moberg M, Gustavsson I, Wilander E, Gyllensten U. 2005. High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer 92:891-894.
33. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, DarraghT, Palefsky J. 2001. Risks for incident human papillomavirus infection and low-grade squa- mous intraepithelial lesion development in young females. JAMA 285:2995-3002.
34. Oh KJ, Kalinina A, Park NH, Bagchi S. 2006. Deregulation of eIF4E: 4E-BP1 in differentiated human papillomavirus- containing cells leads to high levels of expression of the E7 oncoprotein. J Virol 80:7079-7088.
35. Oikonomou P, Mademtzis I, Messinis I, Tsezou A. 2006. Quantitative determination of human telomerase reverse transcriptase messenger RNA expression in premalignant cervical lesions and correlation with human papillomavirus load. Hum Pathol 37:135-142.
36. Rajeevan MS, Swan DC, Nisenbaum R, Lee DR, Vernon SD, Ruffin MT, Horowitz IR, Flowers LC, Kmak D, Tadros T, Birdsong G, Husain M, Srivastava S, Unger ER. 2005. Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer 115:114-120.
37. Rohan TE. 2004. The epidemiology of adenocarcinoma of the cervix. In: Rohan TE, Shah KV, editors. Cervical cancer: From etiology to prevention. Dordrecht, The Netherlands: Kluwer Academic Publishers.
38. Santos AL, Derchain SF, Martins MR, Sarian LO, Martinez EZ, Syrjanen KJ. 2003. Human papillomavirus viral load in predicting high-grade CIN in women with cervical smears showing only atypical squamous cells or low-grade squamous intraepithelial lesion. Sao Paulo Med J 121:238-243.
39. Scheurer ME, Tortolero-Luna G, Guillaud M, Follen M, Chen Z, Dillon LM, Adler-Storthz K. 2005. Correlation of human papillomavirus type 16 and human papillomavirus type 18 e7 messenger RNA levels with degree of cervical dysplasia. Cancer Epidemiol Biomar- kersPrev 14:1948-1952.
40. Schlecht NF, Trevisan A, Duarte- Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. 2003. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer 103:519-524.
41. Snijders PJ, Hogewoning CJ, Hesselink AT, Berkhof J, Voorhorst FJ, Bleeker MC, Meijer CJ. 2006. Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 31 and 33-positive women with normal cytology. Int J Cancer 119:1102-1107.
42. Stacey SN, Jordan D, Williamson AJ, Brown M, Coote JH, Arrand JR. 2000. Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNA. J Virol 74:7284-7297.
43. Sun CA, Lai HC, Chang CC, Neih S, Yu CP, Chu TY. 2001. The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gynecol Oncol 83:95 -99.
44. Sun CA, Liu JF, Wu DM, Nieh S, Yu CP, Chu TY. 2002. Viral load of high-risk human papillomavirus in cervical squamous intraepithe- lial lesions. Int J Gynaecol Obstet 76:41 -47.
45. Swan DC, Tucker RA, Tortolero- Luna G, Mitchell MF, Wideroff L, Unger ER, Nisenbaum RA, Reeves WC, Icenogle JP. 1999. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol 37:1030-1034.
46. Tang S, Tao M, McCoy JP, Jr., Zheng ZM. 2006. The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. J Virol 80:4249-4263.
47. Therneau TM, Grambsch PM. 2000. Modeling survival data: Extending the Cox model. New York: Springer.
48. Tsai HT, Wu CH, Lai HL, Li RN, Tung YC, Chuang HY, Wu TN, Lin LJ, Ho CK, Liu HW, Wu MT. 2005. Association between quantitative high-risk human papillomavirus DNA load and cervical intrae- pithelial neoplasm risk. Cancer Epidemiol Biomarkers Prev 14:2544-2549.
49. Tucker RA, Unger ER, Holloway BP, Swan DC. 2001. Real-time PCR- based fluorescent assay for quantitation of human papillomavirus types 6, 11 16, and 18. Mol Diagn 6:39-47.
50. van Duin M, Snijders PJ, Schrijnemakers HF, Voorhorst FJ, Rozendaal L, Nobbenhuis MA, van den Brule AJ, Verheijen RH, Helmerhorst TJ, Meijer CJ. 2002. Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearance. Int J Cancer 98:590-595.
51. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G Hallmans G, Dillner J. 1999. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341:1633-1638.
52. Wang SS, Hildesheim A. 2003. Chapter 5: Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr 31:35-40.
53. Wang-Johanning F, Lu DW, Wang Y, Johnson MR, Johanning G L 2002. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep papanicolaou tests using real-time polymerase chain reaction analysis. Cancer 94:2199-2210.
54. Winer RL, Koutsky L. 2004. The epidemiology of human papilloma- virus infections. In: Rohan TE, Shah KV, editors. Cervical cancer From etiology to prevention. Dordrecht, The Netherlands: Kluwer Academic Publishers. pp. 143-187.
55. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA 2003. Incident infection with genital human papillomavirus: Rates and risk factors among a cohort of female university students. Am J Epidemiol 157:218-226.
56. Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, Holmes KK, Koutsky LA. 2006. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 354:2645-2654.
57. Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates:M Rollason TP, Young LS. 2001. Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study. Lancet 357:1831 -1836. Wu Y, Chen Y, Li L, Yu G, Zhang Y, He Y. 2006. Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 35:264-269.
58. LF, Kiviat NB, Galloway DA, Zhou XH, Ho J, Koutsky LA. 2008( Effect of cervical cytologic status on the association between human papillomavirus type 16 DNA load and the risk of cervical intraepithelial neoplasia grade 3. J Infect Dis 198:324-331.
59. LF, Koutsky LA, Castle PE, Wheeler CM, Galloway DA, Mao C, Ho J Kiviat NB. 2009. Human papillomavirus type 18 DNA load and 2- year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3. J Natl Cancer Inst 101:153-161. Ylitalo N, Sorensen P, Josefsson AM, Magnusson PK, Andersen PK Ponten J, Adami HO, Gyllensten UB, Melbye M. 2000. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: A nested case-control study. Lancet 355:2194-2198.
60. Zerbini M, Venturoli S, Cricca M, Gallinella G, De Simone P, Costa S, Santini D, Musiani M. 2001. Distribution and viral load of type specific HPVs in different cervical lesions as detected by PCR- ELISA. J Clin Pathol 54:377-380.